ASCIA Education Projects

Anaphylaxis | Food Allergy | Respiratory/Insect Allergy  | Drug Allergy | Skin/Allergy | Immunodeficiency | Testing | COVID-19   

The ASCIA team works with ASCIA committees and working parties to review, update and develop accessible, consistent and evidence based resources, education and training, to support ASCIA members, other health professionals, patients, carers and the community. 

 ASCIA Anaphylaxis Resources 

The following resources have been developed and/or updated in 2021.

Action Plans, Forms and Checklists


ASCIA Action Plan FAQs Updated June 2021
 
 
 
 
 
 
Anaphylaxis Checklist for Patients Updated September 2021
 
 
 
Adrenaline Injector Information
 
 

Adrenaline Injectors for General Use Updated September 2021
 
Adrenaline Injector Supply Updates Updated September 2021

Adrenaline Injectors FAQ Updated September 2021
 
Information for Patients, Consumers and Carers 
 

Anaphylaxis Patient Information - English Updated September 2021

Guidelines for Health Professionals

Anaphylaxis Guidelines - Health Professionals Updated July 2021

ASCIA Anaphylaxis e-Training Courses

 
 
Anaphylaxis e-training - Community Updated September 2021
 

ASCIA Food Allergy Resources 

The following resources have been developed and/or updated in 2021.

Information for Patients, Consumers and Carers - Food Allergy

Food Allergy FAQ Updated May 2021

Oral Immunotherapy (OIT) for Food Allergy FAQ New April 2021

ASCIA Dietary Avoidance for Food Allergy FAQ New May 2021 

ASCIA Dietary Guide for Cow's Milk and Soy Allergy New May 2021

Information for Patients, Consumers and Carers - Other Adverse Reactions to Foods

Oral Allergy Syndrome FAQ New September 2021

Sulfite Sensitivity FAQ Updated July 2021

Eosinophilic Oesophagitis (EoE) FAQ New July 2021

Eosinophilic Oesophagitis (EoE) Dietary Guide - 2FED New July 2021

Eosinophilic Oesophagitis (EoE) Dietary Guide - 4FED New July 2021

Action and Management Plans

Eosinophilic Oesophagitis (EoE) Action Plan New July 2021

Eosinophilic Oesophagitis (EoE) Management Plan New July 2021

Information for Health Professionals

ASCIA Position Paper - Oral Immunotherapy for Food Allergy New April 2021

ASCIA Position Statement - Packaged Foods for Infants that Contain Most of the Common Food Allergens New April 2021

The following project is scheduled to be completed in 2021:

  • Updated ASCIA Food Allergy e-training and reference list 

ASCIA Respiratory and Insect Allergy Resources 

The following resources have been developed and/or updated in 2021. 

ASCIA Treatment Plan – Subcutaneous Immunotherapy (SCIT) Updated May 2021

ASCIA Treatment Plan - Sublingual Immunotherapy (SLIT) New June 2021

The following projects are scheduled to be completed in 2021:

  • New ASCIA Position Paper on Chronic Rhinosinusitis with Nasal Polyps
  • Updated ASCIA Allergen Immunotherapy e-training for health professionals

ASCIA Drug (Medication) Allergy Resources 

The following resources have been developed and/or updated in 2021.

ASCIA Action Plan for Drug (Medication) Allergy Updated June 2021

ASCIA Record for Drug (Medication) Allergy Updated June 2021

ASCIA Consensus Statement - Cephalosporin Allergy (available to Members only) New July 2021

ASCIA Skin/Allergy Resources 

The following resources have been developed and/or updated in 2021. 

Eczema (Atopic Dermatitis) FAQ Updated August 2021

ASCIA Action Plan for Eczema Updated August 2021

ASCIA Stepwise Management Plan for Eczema Updated August 2021

The following project is scheduled to be completed in 2021:
  • New ASCIA Atopic Dermatitis (Eczema) information for health professionals 

ASCIA Immunodeficiency Resources 

The following resources have been developed and/or updated in 2021. 

Information for Patients, Consumers and Carers

Subcutaneous Immunoglobulin (SCIg) Therapy - General Information Updated August 2021

Information for Health Professionals

The following projects are scheduled to be completed in 2021-2022:

  • New ASCIA immunoglobulin replacement therapy (IRT) e-training for health professionals 
  • New ASCIA hereditary angioedema (HAE) e-training for health professionals 
  • Updated ASCIA primary immunodeficiency (PID) e-training for health professionals 
  • New ASCIA HAE patient information
  • New ASCIA immune system and immunodeficiency animations
  • Launch and implementation of ASCIA Immunodeficiency Strategy in February 2022 www.nationalimmunodeficiencystrategy.org.au  

ASCIA Testing Resources 

The following resources have been developed and/or updated in 2021. 
 
Information for Patients, Consumers and Carers
 
  
Information for Health Professionals 
 

ASCIA COVID-19 Resources 

The following resources have been developed and/or updated in 2021.

Information for Patients, Consumers and Carers 

Allergy, Immunodeficiency, Autoimmunity and COVID-19 Vaccination - Frequently Asked Questions (FAQ) for patients, consumers and carers Updated September 2021

COVID-19 and Immunodeficiency Updated August 2021

Information for Health Professionals  

COVID-19 Vaccination Guidelines for Clinical Immunology/Allergy Specialists Updated September 2021

Allergy, Immunodeficiency, Autoimmunity and COVID-19 Vaccination - Position Statement for health professionals Updated September 2021

Allergy and COVID-19 Vaccination - Guide for health professionals Updated September 2021

 

Improving Access to ASCIA information

ReadSpeaker is available on the ASCIA webpages (html, not pdfs) for patients, consumers and carers, to improve access for people with:
  • Vision impairment, limited reading ability or learning disabilities, by allowing text to speech (TTS).
  • Non-English speaking backgrounds - information can be translated into 20 different languages by highlighting the text and selecting 'translate’.
 
Content updated September 2021
Mod ASCIA Member
Donate to AIFA
go to NAS website
About ASCIA

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links

About ASCIA

ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Accreditiation

healthdirect

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.